Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.55 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.44 |
| ▸ | PRKDC | P78527 | 5/20 | 0.41 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.39 |
| ▸ | ACACA | Q13085 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19397601 | 0.96 | ALOX5 (0.51) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL19397496 | 0.96 | ALOX5 (0.54) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL19397382 | 0.96 | ALOX5 (0.50) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL9881126 | 0.96 | ALOX5 (0.53) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL17879060 | 0.96 | ALOX5 (0.53) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL17899189 | 0.96 | ALOX5 (0.53) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL15501947 | 0.96 | ALOX5 (0.53) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL9881120 | 0.96 | ALOX5 (0.53) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL16441384 | 0.96 | ALOX5 (0.51) | ALOX5GGPS1PRKDCPTGES2TSHR | |
| SCHEMBL19397402 | 0.95 | ALOX5 (0.50) | ALOX5GGPS1PRKDCPTGES2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2020-03-03 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | C1S, AOC2, L1CAM | ALOX5 2060/4885GGPS1 1950/4885PRKDC 4294/4885 |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | L1CAM, C1S, F10 | ALOX5 2055/4885GGPS1 1786/4885PRKDC 4720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.